$ZTS News

Stifel Maintains Hold on Zoetis, Lowers Price Target to $80

Zoetis: Another Bad Quarter, Some Value Trap Risk But Shares Still Cheap

Zoetis: The Growth Story Has Broken, But The Valuation Finally Makes Sense

Michael Burry-Backed ZTS Stock Climbs Following FDA Green Light For Dog Pill Against Screwworm

Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies

Zoetis (ZTS) Q2 2026 Earnings Call Transcript

BNP Paribas Maintains Outperform on Zoetis, Lowers Price Target to $110

Zoetis Stock: Is Wall Street Bullish or Bearish?

Piper Sandler Maintains Neutral on Zoetis, Lowers Price Target to $80

Zoetis (ZTS) Looked Like a Winner. What Went Wrong?

ZTS Q2 Deep Dive: Leadership Shifts and Competitive Pressures Shape Guidance

Zoetis Q2 Earnings Call Highlights

UBS Maintains Neutral on Zoetis, Lowers Price Target to $80

Zoetis (ZTS) Following Earnings And Guidance Cut With A Valuation Question

Zoetis nabs GE Health CFO for dual finance chief, COO role

JP Morgan Maintains Overweight on Zoetis, Lowers Price Target to $115

ZTS Q2 Earnings Call Flags Deeper Companion Animal Pressure

William Blair Downgrades Zoetis (ZTS)

Zoetis Inc (ZTS) (Q2 2026) Earnings Call Highlights: Navigating Market Headwinds with Strategic ...

Zoetis Inc. Q2 2026 Earnings Call Summary